Pfizer Inc. PFE
Set alert
30.67 USD 0.00 0.00%
At close
30.42 -0.25 -0.83%
Pre-market · Nov 3, 9:11 AM ET
Day range unavailable
23.62 52-week range 31.04
- YTD
- +23.17%
- 1 year
- +24.37%
- Open
- —
- Prev close
- 30.67
- Mkt cap
- 174.81B
- Vol
- 0
- Avg vol
- 33.91M
- EPS
- 0.76
- P/E
- 40.36
- Div yield
- 5.74%
More statistics
- Low
- —
- High
- —
- Forward P/E
- 10.64
- Beta
- 0.30
- Short ratio
- 4.20
- Inst. own
- 69.11%
- Dividend
- 1.72
- Ex-div date
- Nov 5, 2026
- Earnings
- Nov 3, 2026
- 50-d avg
- 28.55
- 200-d avg
- 26.80
- 1y target
- 29.26
5D chart
Signals (89)
| Name | Time | Ago |
|---|---|---|
| SMA: Bearish | Nov 2, 3:40 PM | 17 hours ago |
| SMA: Bullish | Nov 2, 3:25 PM | 17 hours ago |
| SMA: Bearish | Nov 2, 3:20 PM | 17 hours ago |
| SMA: Bullish | Nov 2, 3:15 PM | 17 hours ago |
| SMA: Bearish | Nov 2, 3:10 PM | 18 hours ago |
| MACD: Sell Signal | Nov 2, 2:50 PM | 18 hours ago |
| MACD: Buy Signal | Nov 2, 2:45 PM | 18 hours ago |
| RSI: Overbought | Nov 2, 2:35 PM | 18 hours ago |
| MACD: Sell Signal | Nov 2, 2:25 PM | 18 hours ago |
| RSI: Overbought | Nov 2, 1:35 PM | 19 hours ago |
| RSI: Overbought | Nov 2, 12:55 PM | 20 hours ago |
| SMA: Bullish | Nov 2, 12:00 PM | 21 hours ago |
| MACD: Buy Signal | Nov 2, 12:00 PM | 21 hours ago |
| MACD: Sell Signal | Nov 2, 11:50 AM | 21 hours ago |
| SMA: Bullish | Nov 2, 11:40 AM | 21 hours ago |
| SMA: Bearish | Nov 2, 11:35 AM | 21 hours ago |
| SMA: Bearish | Nov 2, 11:30 AM | 21 hours ago |
| SMA: Bullish | Nov 2, 11:00 AM | 22 hours ago |
| MACD: Buy Signal | Nov 2, 10:45 AM | 22 hours ago |
| SMA: Bullish | Nov 2, 10:35 AM | 22 hours ago |
Newest 20 of 89.
Analyst view
Consensus: buy
Buy
Price target (mean) 29.26 -4.6% downside
Now 30.67
- Target (low)
- 25.00
- Target (mean)
- 29.26
- Target (high)
- 36.00
Ratings (0m) 28 9 buy · 17 hold · 2 sell
- Strong buy1
- Buy8
- Hold17
- Sell1
- Strong sell1
Recommendation trend
- This month 28
- 1 month ago 28
- 2 months ago 28
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.72803 | 0.56 – 0.83 | 0.87 | -16.3% | 15.88B | -4.7% | 19 |
| Next quarter | 0.70613 | 0.63 – 0.83 | 0.66 | +7.0% | 16.89B | -3.8% | 17 |
| Current year | 2.96 | 2.88 – 3.07 | 3.22 | -8.1% | 62.23B | -0.5% | 24 |
| Next year | 2.89 | 2.52 – 3.15 | 2.96 | -2.4% | 59.89B | -3.8% | 22 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 9, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Oct 8, 2026 | Cantor Fitzgerald | Maintained | Neutral | Neutral |
| Oct 6, 2026 | Scotiabank | Maintained | Sector Outperform | Sector Outperform |
| Sep 10, 2026 | HSBC | Maintained | Hold | Hold |
| Aug 7, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jul 13, 2026 | BMO Capital | Maintained | Outperform | Outperform |
| Jul 13, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jul 10, 2026 | B of A Securities | Maintained | Neutral | Neutral |
| Jul 8, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Jul 6, 2026 | Cantor Fitzgerald | Reiterated | Neutral | Neutral |
| Jul 6, 2026 | HSBC | Downgrade | Buy | Hold |
| Jun 10, 2026 | RBC Capital | Upgrade | Underperform | Sector Perform |
| Apr 29, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Apr 20, 2026 | RBC Capital | Reiterated | Underperform | Underperform |
| Apr 16, 2026 | CICC | Initiated | — | Outperform |
| Apr 13, 2026 | UBS | Maintained | Neutral | Neutral |
| Apr 10, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Apr 9, 2026 | B of A Securities | Maintained | Neutral | Neutral |
| Mar 24, 2026 | Guggenheim | Maintained | Buy | Buy |
| Mar 17, 2026 | HSBC | Maintained | Buy | Buy |
| Mar 2, 2026 | Argus Research | Upgrade | Hold | Buy |
| Feb 25, 2026 | RBC Capital | Initiated | — | Underperform |
| Feb 20, 2026 | Barclays | Initiated | — | Underweight |
| Feb 9, 2026 | Freedom Broker | Maintained | Buy | Buy |
| Feb 4, 2026 | Cantor Fitzgerald | Reiterated | Neutral | Neutral |
| Jan 27, 2026 | Cantor Fitzgerald | Maintained | Neutral | Neutral |
| Dec 17, 2025 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Dec 15, 2025 | B of A Securities | Maintained | Neutral | Neutral |
| Dec 12, 2025 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Nov 24, 2025 | Guggenheim | Maintained | Buy | Buy |
